Crop Life Science (NSE:CLSL) Operating Income: ₹128 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CLSL Crop Life Science Ltd NSE:CLSL
56 GF Score
Price ₹60.40
GF Value ₹55.35
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Crop Life Science Operating Income?

Crop Life Science NSE:CLSL +14.07% 56 Operating Income is ₹128 Mil as of Mar. 2026. GuruFocus rates NSE:CLSL with a GF Score™ of 56/100 and a GF Value™ of ₹55.35 (Fairly Valued). The stock has 8 warning signs investors should review.

Crop Life Science's Operating Income for the six months ended in Mar. 2026 was ₹71 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₹128 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Crop Life Science's Operating Income for the six months ended in Mar. 2026 was ₹71 Mil. Crop Life Science's Revenue for the six months ended in Mar. 2026 was ₹869 Mil. Therefore, Crop Life Science's Operating Margin % for the quarter that ended in Mar. 2026 was 8.17%.

Good Sign:

Crop Life Science Ltd operating margin is expanding. Margin expansion is usually a good sign.

Crop Life Science's 5-Year average Growth Rate for Operating Margin % was 1.20% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Crop Life Science's annualized ROC % for the quarter that ended in Mar. 2026 was 6.48%. Crop Life Science's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 11.39%.

Crop Life Science  (NSE:CLSL) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Crop Life Science's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=142.026 * ( 1 - 30.02% )/( (1547.982 + 1517.308)/ 2 )
=99.3897948/1532.645
=6.48 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2195.265 - 621.498 - ( 25.785 - max(0, 1279.69 - 1867.186+25.785))
=1547.982

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2079.529 - 526.131 - ( 36.09 - max(0, 1137.926 - 1766.585+36.09))
=1517.308

Note: The Operating Income data used here is two times the semi-annual (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Crop Life Science's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=157.794/( ( (290.955 + max(1091.465, 0)) + (275.679 + max(1113.59, 0)) )/ 2 )
=157.794/( ( 1382.42 + 1389.269 )/ 2 )
=157.794/1385.8445
=11.39 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(809.994 + 695.29 + 336.117) - (621.498 + 0 + 128.438)
=1091.465

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(741.447 + 705.555 + 283.493) - (526.131 + 0 + 90.774)
=1113.59

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Crop Life Science's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=71.013/869.017
=8.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Crop Life Science Operating Income Related Terms

Crop Life Science Operating Income Historical Data

* Premium members only.

The historical data trend for Crop Life Science's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crop Life Science Operating Income Chart

Crop Life Science Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Operating Income
Get a 7-Day Free Trial 54.60 83.44 94.23 115.32 128.36

Crop Life Science Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 46.79 60.44 55.55 57.34 71.01
NSE:CLSL
56GF Score
Crop Life Science Ltd NSE:CLSL
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crop Life Science Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹128 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of ₹128 Mil mean?
Crop Life Science (NSE:CLSL) has a Operating Income of ₹128 Mil as of Mar. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Crop Life Science and its competitors.
Is Crop Life Science's Operating Income too high?
Crop Life Science's current Operating Income is ₹128 Mil. Overall, Crop Life Science has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's Operating Income compare to CTVA and CF?
Crop Life Science's Operating Income of ₹128 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for an Agriculture company?
A good Operating Income depends on the Agriculture industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Crop Life Science and its competitors. Crop Life Science's current Operating Income is ₹128 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Fairly Valued. The stock's GF Value™ is ₹55.35, compared to a current price of ₹60.40 — trading 9.1% above its estimated fair value. The current Operating Income is ₹128 Mil. Crop Life Science's overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current Operating Income is ₹128 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crop Life Science (NSE:CLSL) Overvalued in 2026?

Based on GuruFocus' analysis, Crop Life Science stock appears to be overvalued. The current stock price of ₹60.40 is trading 9.1% above its estimated GF Value™ of ₹55.35. GuruFocus considers Crop Life Science to be Fairly Valued.

Key valuation signals for NSE:CLSL:

  • Operating Income: ₹128 Mil
  • GF Value™: ₹55.35 vs. price of ₹60.40 (9.1% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crop Life Science Business Description

Address Old Padra Road, 6th Floor, ABS Tower, Near Chakli Circle, Vadodara, GJ, IND, 390007
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
56GF Score

Get the complete analysis for NSE:CLSL

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹60.40
Price
₹55.35
GF Value